GlassScriptPhysician profile
Andrew T Lemchen
NPI 1639690274
$2,589.60
in general payments reported to CMS, 2019-2025
12 companies · $929 in 2025
The $929 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $65.78 · 2023: $691 · 2024: $548 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Education: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.01 |
| Education | $231.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $616.05 | 2024-2025 | Spark, Ortho Solo |
| Align Technology, INC. | $330.99 | 2025 | Invisalign |
| Ormco Corporation | $305.69 | 2021-2023 | Spark, Red, White and Blue Retainer |
| Kavo Dental Technologies LLC | $264.57 | 2023 | |
| Nobel Biocare USA | $213.43 | 2023 | Nobelactive |
| 3m Company | $203.69 | 2021 | |
| Straumann USA LLC | $197.00 | 2024 | |
| Dental Monitoring Sas | $145.27 | 2025 | |
| Ultradent Products INC | $125.48 | 2021 | |
| Lightforce Orthodontics, INC. | $97.51 | 2025 | |
| Ortho Organizers, INC. | $68.85 | 2025 | Carriere, Transforce Sagittal |
| American Orthodontics Corporation | $21.07 | 2024 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lemchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.